Tag: Clinical Trials

Clinical trials are experiments or observations done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments (such as novel vaccines, drugs, dietary choices, dietary supplements, and medical devices) and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy. They are conducted only after they have received health authority/ethics committee approval in the country where approval of the therapy is sought. These authorities are responsible for vetting the risk/benefit ratio of the trial – their approval does not mean that the therapy is ‘safe’ or effective, only that the trial may be conducted.

LakePharma launches GMP biomanufacturing center

LakePharma, Inc., the leading US-based biologics company specializing in antibody and protein engineering, cell line development and protein production, announced the launch of the LakePharma MicroBiomanufacturing (GMP) Center

Parexel launched its Biological Sample Lifecycle Management service

PAREXEL International Corporation, the world’s leading innovator of biopharmaceutical services, launched its Biological Sample Lifecycle Management service, enabling optimal use of human biological samples.

DNAnexus launches cloud-based clinical trials solution

DNAnexus, the global leader in biomedical informatics and data management, announced the availability of its Clinical Trial Solution which streamlines the use of next-generation sequencing data in regulated clinical trials

Theravance Biopharma and Janssen entered into drug development collaboration

Theravance Biopharma Ireland announced that it has entered into a global co-development and commercialization agreement with Janssen Biotech, Inc., for TD-1473 and related back-up compounds for inflammatory intestinal diseases

Medsenic raised funding to develop the treatment for autoimmune diseases

Medsenic, a French biopharmaceutical company, raised €2 million funding. These funds will allow it to continue research on arsenic trioxide and promising clinical trials of autoimmune diseases.

Obninsk laboratory will speed up the market launch of the modern drugs

A laboratory for early studies of pharmaceuticals intended to treat cancer will be opened in the city of Obninsk, Kaluga region. It will allow to accelerate the market launch of the modern drugs manuf...

Moderna Therapeutics raised $500 million funding for drug development

Moderna Therapeutics, a clinical stage biotechnology company that is pioneering mRNA therapeutics and vaccines, raised $500 million in a new funding round

Medidata and Syapse announced a partnership focused on clinical trials

clinical trials
Medidata, the leading global provider of cloud-based technology and data analytics for clinical research, and Syapse, a market leader in precision medicine solutions, have announced a new partnership

Syndax entered a clinicial trial collaboration with AstraZeneca

drug development
Syndax Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced a new clinical collaboration with AstraZeneca

CTI Clinical Trial and Consulting Services opened new location in Singapore

clinical trials
CTI Clinical Trial and Consulting Services, a multi-national, privately held, full-service contract research organization announces that it has opened offices in Singapore

Innate Pharma and MedImmune started a new clinical trial collaboration

cancer lab diagnostic
Innate Pharma announced that it has entered into a clinical trial collaboration with MedImmune, the global biologics research and development arm of AstraZeneca

Marken will open a new logistic hub in Germany

clinical trials
Marken, a patient-centric supply chain organization, announced it will open a third branch in Germany in the first quarter of 2018 to meet new demands in the region

An international research team tests a novel malaria treatment

clinical trial
An international research team has conducted successful phase II clinical tests of a new anti-malaria medication. The new combination of drugs was developed by Tübingen Institute and DMG Deutschen Malaria.

CRO Biorasi opens a new office in Tokyo

clinical trials
Biorasi, a leading full-service global CRO, announced the opening of their new Japanese office, located in Tokyo. The new office will become the command center for all East-Asian operations.

Gilead starts a new clinical collaboration with Pfizer

Kite, a Gilead Company, announced a clinical trial collaboration with Pfizer to evaluate the safety and efficacy of the investigational combination of Yescarta and Pfizer's utomilumab

French biotech company Neovacs obtained a new patent in Russia

Neovacs announced that it has been granted a new patent from the Russian Federation Patent Office, titled: "Method of treatment of a disease related to the overexpression of IFNalpha"